Avenida Vital Brasil 1500
São Paulo, 05503-900, Brazil
NCT Number: NCT04408014
Seroepidemiological Study of SARS-CoV-2 Infection in Population Subgroups in the State of São Paulo
Looking for future studies?
Notify Me6 month–100 year
All sexes
Observational
São Paulo, 05503-900, Brazil
This is a cross-sectional study to estimate the prevalence of antibodies against SARS-CoV-2 is different population subgroups in the State of São Paulo
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
IgM and IgG for SARS-CoV-2
PCR for SARS-CoV-2
PCR for SARS-CoV-2
Time frame: 1 month
IgM and IgG antibodies against SARS-CoV-2
Time frame: 1 month
Positive RT-PCR test result for SARS-CoV-2
Butantan Institute
Other Gov
Seroepidemiological Study of SARS-CoV-2 Infection in Population Subgroups in the State of São Paulo
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04368143
B Cell, COVID
Antwerp, Belgium
View Trial DetailsNCT04756518
COVID, COVID-19
Ipswich, United Kingdom
View Trial DetailsNCT04385251
COVID, COVID-19
Denver, Colorado, United States
View Trial DetailsNCT04357834
COVID, COVID 19
Bern, Switzerland
View Trial Details